Psychosocial Risk Factors for Alzheimer’s Disease in Patients with Down Syndrome and Their Association with Brain Changes: A Narrative Review

被引:0
|
作者
Osama Hamadelseed
Ibrahim H. Elkhidir
Thomas Skutella
机构
[1] University of Heidelberg,Department of Neuroanatomy, Institute of Anatomy and Cell Biology
[2] University of Khartoum,Faculty of Medicine
来源
Neurology and Therapy | 2022年 / 11卷
关键词
Alzheimer’s disease; Corpus callosum; Dementia; Down syndrome; Hippocampus; Psychosocial risk factors;
D O I
暂无
中图分类号
学科分类号
摘要
Several recent epidemiological studies attempted to identify risk factors for Alzheimer’s disease. Age, family history, genetic factors (APOE genotype, trisomy 21), physical activity, and a low level of schooling are significant risk factors. In this review, we summarize the known psychosocial risk factors for the development of Alzheimer’s disease in patients with Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. We completed a comprehensive review of the literature on PubMed, Google Scholar, and Web of Science about psychosocial risk factors for Alzheimer’s disease, for Alzheimer’s disease in Down syndrome, and Alzheimer’s disease in Down syndrome and their association with neuroanatomical changes in the brains of people with Down syndrome. Alzheimer’s disease causes early pathological changes in individuals with Down syndrome, especially in the hippocampus and corpus callosum. People with Down syndrome living with dementia showed reduced volumes of brain areas affected by Alzheimer’s disease as the hippocampus and corpus callosum in association with cognitive decline. These changes occur with increasing age, and the presence or absence of psychosocial risk factors impacts the degree of cognitive function. Correlating Alzheimer’s disease biomarkers in Down syndrome and cognitive function scores while considering the effect of psychosocial risk factors helps us identify the mechanisms leading to Alzheimer’s disease at an early age. Also, this approach enables us to create more sensitive and relevant clinical, memory, and reasoning assessments for people with Down syndrome.
引用
收藏
页码:931 / 953
页数:22
相关论文
共 50 条
  • [21] Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome
    Barone, Eugenio
    NEURAL REGENERATION RESEARCH, 2022, 17 (02) : 333 - 335
  • [22] Brain insulin resistance: an early risk factor for Alzheimer's disease development in Down syndrome
    Eugenio Barone
    Neural Regeneration Research, 2022, 17 (02) : 333 - 335
  • [23] Thyroid stimulating hormone - Receptor overexpression in brain of patients with Down Syndrome and Alzheimer's disease
    Labudova, O
    Cairns, N
    Koeck, T
    Kitzmueller, E
    Rink, H
    Lubec, G
    LIFE SCIENCES, 1999, 64 (12) : 1037 - 1044
  • [24] Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome
    Musaeus, Christian Sandoe
    Salem, Lise Cronberg
    Kjaer, Troels Wesenberg
    Waldemar, Gunhild
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [25] Biomarker Course of Alzheimer's Disease in Patients with Down Syndrome
    Gappa, Birgit
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (18) : 1290 - 1290
  • [26] Alzheimer disease and Down syndrome: factors in pathogenesis
    Lott, IT
    Head, E
    NEUROBIOLOGY OF AGING, 2005, 26 (03) : 383 - 389
  • [27] Epidemiological of and risk factors for Alzheimer's disease: A review
    Povova, Jana
    Ambroz, Petr
    Bar, Michal
    Pavukova, Veronika
    Sery, Omar
    Tomaskova, Hana
    Janout, Vladimir
    BIOMEDICAL PAPERS-OLOMOUC, 2012, 156 (02): : 108 - 114
  • [28] Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
    Aschenbrenner, Andrew J.
    Baksh, R. Asaad
    Benejam, Bessy
    Beresford-Webb, Jessica A.
    Coppus, Antonia
    Fortea, Juan
    Handen, Benjamin L.
    Hartley, Sigan
    Head, Elizabeth
    Jaeger, Judith
    Levin, Johannes
    Loosli, Sandra, V
    Rebillat, Anne-Sophie
    Sacco, Silvia
    Schmitt, Frederick A.
    Thurlow, Kate E.
    Zaman, Shahid
    Hassenstab, Jason
    Strydom, Andre
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [29] The impact of Alzheimer disease on the brain's white matter development in individuals with Down syndrome: a systematic review
    Saini, F.
    Dell'Acqua, F.
    Strydom, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S544 - S545
  • [30] Sex differences in risk of Alzheimer's disease in adults with Down syndrome
    Lai, Florence
    Mhatre, Pooja G.
    Yang, Yuchen
    Wang, Mei-Cheng
    Schupf, Nicole
    Rosas, H. Diana
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)